Icagen, Inc. (ICGN) is “One to Watch”
Icagen, a biopharmaceutical company, focuses on discovering, developing and commercializing novel small molecule drugs that modulate ion channel targets. The company has developed an integrated technology platform that enables the efficient discovery of drug leads. Ion channels are protein structures found in nearly every cell of the human body. These channels span the cell membrane and regulate the flow of ions, charged particles such as sodium, potassium, calcium and chloride, into and out of cells. Currently, there are 35 drugs that modulate ion channels which are marketed by third parties for multiple therapeutic indications. Icagen utilizes a target class approach…
